Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
AT A GLANCE: Clinical trials serve as the crucial bridge between groundbreaking laboratory research and the eventual approval of new treatments or interventions. At the Waisman Center, researchers like Albee Messing, VMD, PhD, and David Gamm, MD, PhD have dedicated decades to transforming innovative ideas into potential therapies, now undergoing rigorous testing to ensure their …
A new test may spur advances in drug discovery for a rare and debilitating neurological disorder. Charcot-Marie-Tooth disease, a rare inherited neurological disorder, affects more than 2.8 million people around the globe.
A story in the Milwaukee Journal Sentinel reflects on the history of stem cells and its future direction. Two decades after the first stem cell breakthrough, the promising biological discovery is beginning to take steps toward clinical trials. Waisman Center investigator David Gamm, who researches stem cell therapies for diseases of the eye, reflects on …
